Strong Surgery, Soft Quarter: ATEC and the Cost of the Capital Bet (opens in new tab)
There is a version of Alphatec’s first quarter that reads like a growth story, and a version that reads like a warning. Both are true, and the distance between them is the most useful thing to study in spine right now. The growth story first. Surgical revenue reached $178 million, up 17% year over year, […]
Read the original article